Insider filing · TENX
Tenax Therapeutics, Inc.
TENX · Healthcare · 5 filings in 24 months
ticker →
ADAR1 Capital Management, LLC bought $1.5M of Tenax Therapeutics (TENX)
Executed Oct 19, disclosed Oct 21, 2 days later.
Value, as filed
$1.5M
922,849 sh across 3 lots
Executed
Oct 19
the trade date, as filed
Disclosed
Oct 21
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
not yet measured
Not yet measured: the 21-session window has not closed, or the prices around it are not on record.
The filer
AL
ADAR1 Capital Management, LLC
10% owner
profile →
ADAR1 Capital Management, LLC (10% owner) filed 10 Form 4 reports as a reporting entity in the trailing twelve months (10 purchases, 0 sales), most often in Rallybio Corporation (RLYB). Across 9 priced purchase filings, the average 21-session return was +5.2% from execution and +12.8% from disclosure (delay-adjusted; derived). The largest single filing was $2.1M of RLYB (152,005 sh across 2 lots, as filed), executed May 4.
The name
TENXHealthcare · Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by ADAR1 Capital Management, LLC in TENX
TENXPURCHASE
Tenax Therapeutics, Inc.
$1.6M900,000 sh × $1.78
Exec Sep 3
Filed Sep 8 · 5:16 PM ET TENXPURCHASE Tenax Therapeutics, Inc. $1.4M
770,333 sh across 3 lots
Exec Aug 31
Filed Sep 2 · 5:52 PM ET TENXPURCHASE Tenax Therapeutics, Inc. $1.8M
1,025,867 sh across 3 lots
Exec Aug 20
Filed Aug 24 · 6:12 PM ET